(Q57158932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

James L. Riley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Gerald T Nepom

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

5

Carl H June

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

3

William W Kwok

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

16-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Viral vectors for dendritic cell-based immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

The role of CD4+ T cell responses in antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900017-7

7 January 2021

10.1016/S1521-6616(02)00017-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12584046%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference